ArticleNeuroImmune pharmacology and therapeutics2023

Abnormal brain diffusivity in participants with persistent neuropsychiatric symptoms after COVID-19.

Huajun Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.